A Break-even Tax-subsidy Scheme to Realize First-best Welfare

Autor: Lynch He

Publikováno v: SSRN Electronic Journal.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f75f5c8181b1d13e70420a4e41b122db
https://doi.org/10.2139/ssrn.4083573

Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers

Autor: Metcalfe Kelly A, Foulkes William D, Lynch Henry T, Ghadirian Parviz, Tung Nadine, Olivotto Ivo A, Warner Ellen, Olopade Olufunmilayo, Eisen Andrea, Weber Barbara, McLennan Jane, Sun Ping, Narod Steven A

Publikováno v: Hereditary Cancer in Clinical Practice, Vol 3, Iss 2, Pp 53-57 (2005)

Abstract Purpose To compare the presentation of invasive breast cancer in BRCA1 and BRCA2 mutation carriers with and without prior bilateral oophorectomy. Patients and methods Women with a BRCA1 or BRCA2 mutation with the diagnosis of invasive breast

Externí odkaz: https://doaj.org/article/2cb08e355748496fb37e68b5f2759fe5

Genomewide high-density SNP linkage analysis of non-BRCA1/2 breast cancer families identifies various candidate regions and has greater power than microsatellite studies

Autor: Gonzalez-Neira Anna, Rosa-Rosa Juan, Osorio Ana, Gonzalez Emilio, Southey Melissa, Sinilnikova Olga, Lynch Henry, Oldenburg Rogier A, van Asperen Christi J, Hoogerbrugge Nicoline, Pita Guillermo, Devilee Peter, Goldgar David, Benitez Javier

Publikováno v: BMC Genomics, Vol 8, Iss 1, p 299 (2007)

Abstract Background The recent development of new high-throughput technologies for SNP genotyping has opened the possibility of taking a genome-wide linkage approach to the search for new candidate genes involved in heredity diseases. The two major b

Externí odkaz: https://doaj.org/article/7d4863ca64c3402ea883ba4cd59ff6c5

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Altering the Immunogenicity of Hemagglutinin Immunogens by Hyperglycosylation and Disulfide Stabilization.

Autor: Thornlow DN; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States.; Department of Microbiology, Harvard Medical School, Boston, MA, United States., Macintyre AN; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States., Oguin TH; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States., Karlsson AB; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States., Stover EL; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States., Lynch HE; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States., Sempowski GD; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.; Departments of Medicine and Pathology, Duke University School of Medicine, Durham, NC, United States., Schmidt AG; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States.; Department of Microbiology, Harvard Medical School, Boston, MA, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2021 Oct 07; Vol. 12, pp. 737973. Date of Electronic Publication: 2021 Oct 07 (Print Publication: 2021).